| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
DEO
Diageo
|
Jun 18, 2026 | BUY |
Buy
+522.2% avg upside
18 analysts
|
$99.00
19.31% Upside
|
-1.1% |
|
GB:DGE
Diageo
|
Jun 18, 2026 | BUY |
Buy
+444.8% avg upside
26 analysts
|
$1850.00
17.89% Upside
|
· |
|
BF.B
Brown-Forman B
|
Jun 08, 2026 | HOLD |
Hold
+26.3% avg upside
22 analysts
|
$28.00
0.65% Upside
|
· |
|
GB:0RJI
Anheuser Busch InBev SA/NV
|
May 05, 2026 | BUY |
Strong Buy
+6.0% avg upside
26 analysts
|
$80.00
8.87% Upside
|
· |
|
CCEP
Coca-Cola Europacific Partners
|
Apr 28, 2026 | HOLD |
Strong Buy
-11.0% avg upside
25 analysts
|
$107.00
8.25% Upside
|
+2.7% |
|
BUD
Anheuser-Busch Inbev Sa
|
Feb 12, 2026 | BUY |
Strong Buy
-0.8% avg upside
27 analysts
|
$107.90
27.86% Upside
|
+2.1% |
|
GB:0R6Z
Royal UNIBREW A/S
|
Jan 14, 2025 | HOLD |
Buy
+15.3% avg upside
13 analysts
|
$540.00
26.78% Upside
|
· |
|
GB:FEVR
Fevertree Drinks
|
Jan 14, 2025 | SELL |
Hold
+48.7% avg upside
18 analysts
|
$680.00
16.61% Downside
|
· |
|
IT:CPR
Davide Campari-Milano SpA
|
Jan 14, 2025 | HOLD |
Buy
+42.2% avg upside
18 analysts
|
$6.30
12.23% Upside
|
· |
|
GB:CCH
Coca Cola HBC
|
Jan 14, 2025 | BUY |
Strong Buy
-22.5% avg upside
15 analysts
|
$3200.00
33.36% Downside
|
· |
|
GB:0AI4
Carlsberg AS
|
Jan 14, 2025 | BUY |
Buy
+16.6% avg upside
20 analysts
|
$980.00
11.76% Upside
|
· |
|
NL:HEIA
Heineken NV
|
Jan 14, 2025 | BUY |
Strong Buy
+22.2% avg upside
19 analysts
|
$85.00
14.34% Upside
|
· |
|
FR:RI
Pernod Ricard
|
Jan 14, 2025 | BUY |
Buy
+51.5% avg upside
20 analysts
|
$126.00
90.48% Upside
|
· |
|
FR:RCO
Remy Cointreau
|
Jan 14, 2025 | SELL |
Hold
+138.5% avg upside
16 analysts
|
$50.00
11.93% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.